Alan Cooke
Directeur Général chez Sebela Pharmaceuticals, Inc.
Profil
Alan Cooke is currently the President, Chief Executive Officer & Director at Sebela Pharmaceuticals, Inc. and Sebela Pharmaceuticals Holdings, Inc. He is also the Chairman-Neuroscience Institute at Trinity College Dublin.
Additionally, he serves as a Non-Executive Director at Dignity Sciences Ltd., Director at Cellmax, Inc., and Non-Executive Director at Afimmune Ltd.
Previously, he held the position of President & Chief Executive Officer at Sebela International Ltd.
He also worked as the Vice President-Global Strategic Planning at Elan Corp.
Plc and as the Chief Financial Officer at Amarin Corp.
Plc in 2008.
Prior to that, he was a Principal at KPMG LLP (United Kingdom).
Postes actifs de Alan Cooke
| Sociétés | Poste | Début |
|---|---|---|
| Trinity College Dublin | Corporate Officer/Principal | 11/04/2011 |
Dignity Sciences Ltd.
 Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | Directeur/Membre du Conseil | - |
Afimmune Ltd.
 Afimmune Ltd. Miscellaneous Commercial ServicesCommercial Services Afimmune Ltd. operates as drug discovery and development company. It focuses on developing new medicines on inflammatory conditions of the human primary organs including the heart, the liver and the lung. The company was founded by John Climax and Ronan Lambe and is headquartered in Dublin, Ireland. | Directeur/Membre du Conseil | - |
Sebela Pharmaceuticals, Inc.
 Sebela Pharmaceuticals, Inc. Medical DistributorsDistribution Services Sebela Pharmaceuticals, Inc. engages in the provision of marketing and selling of pharmaceutical prescription products. It specializes in the gastroenterology, dermatology, and women?s health. The company is headquartered in Roswell, GA. | Directeur Général | - |
Cellmax, Inc.
 Cellmax, Inc. BiotechnologyHealth Technology Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA. | Directeur/Membre du Conseil | - |
Sebela Pharmaceuticals Holdings, Inc.
 Sebela Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Sebela Pharmaceuticals Holdings, Inc. is a pharmaceutical company that specializes in gastroenterology and women's health. The private company is based in Roswell, GA and was founded in 1983. The company's focus is on developing innovative therapeutic options for gastrointestinal diseases and women's health. Sebela Pharmaceuticals® has a market-leading position in gastroenterology and is developing next-generation therapeutics with innovative features that help address the needs of women today. The CEO is Alan Cooke. | Directeur Général | - |
Anciens postes connus de Alan Cooke
| Sociétés | Poste | Fin |
|---|---|---|
| AMARIN CORPORATION PLC | Directeur Financier/CFO | 16/05/2008 |
KPMG LLP (United Kingdom)
 KPMG LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services KPMG LLP (United Kingdom) provides audit, advisory, and tax services. Its audit and assurance services encompass accounting advisory, financial reporting publications, financial state audit, internal audit, and revenue recognition. The firm's tax and pension services include statutory residency test, pension, personal tax investigations, tax management consulting, tax technology, legal services, tax value chain, employment issues, indirect tax, and tax policy cycle. KPMG was founded in 1987 and is headquartered in London, the United Kigdom. | Corporate Officer/Principal | - |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMARIN CORPORATION PLC | Health Technology |
| Entreprise privées | 8 |
|---|---|
Sebela International Ltd.
 Sebela International Ltd. Pharmaceuticals: MajorHealth Technology Sebela International Ltd. develops prescription pharmaceutical products. It offers products for dermatology, gastroenterology, and other niche markets. The company was founded on July 30, 2013 and is headquartered in Dublin, Ireland. | Health Technology |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
KPMG LLP (United Kingdom)
KPMG LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services KPMG LLP (United Kingdom) provides audit, advisory, and tax services. Its audit and assurance services encompass accounting advisory, financial reporting publications, financial state audit, internal audit, and revenue recognition. The firm's tax and pension services include statutory residency test, pension, personal tax investigations, tax management consulting, tax technology, legal services, tax value chain, employment issues, indirect tax, and tax policy cycle. KPMG was founded in 1987 and is headquartered in London, the United Kigdom. | Commercial Services |
Dignity Sciences Ltd.
Dignity Sciences Ltd. BiotechnologyHealth Technology Dignity Sciences Ltd. operates as a biopharmaceutical company that focuses on discovering and developing new therapeutics based upon novel semi-synthetic fatty acid and derivatives. It specializes in skin treatments, cardiovascular, and pulmonary diseases. The company was founded in 2010 and is headquartered in Dublin, Ireland. | Health Technology |
Afimmune Ltd.
Afimmune Ltd. Miscellaneous Commercial ServicesCommercial Services Afimmune Ltd. operates as drug discovery and development company. It focuses on developing new medicines on inflammatory conditions of the human primary organs including the heart, the liver and the lung. The company was founded by John Climax and Ronan Lambe and is headquartered in Dublin, Ireland. | Commercial Services |
Sebela Pharmaceuticals, Inc.
Sebela Pharmaceuticals, Inc. Medical DistributorsDistribution Services Sebela Pharmaceuticals, Inc. engages in the provision of marketing and selling of pharmaceutical prescription products. It specializes in the gastroenterology, dermatology, and women?s health. The company is headquartered in Roswell, GA. | Distribution Services |
Cellmax, Inc.
Cellmax, Inc. BiotechnologyHealth Technology Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA. | Health Technology |
Sebela Pharmaceuticals Holdings, Inc.
Sebela Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Sebela Pharmaceuticals Holdings, Inc. is a pharmaceutical company that specializes in gastroenterology and women's health. The private company is based in Roswell, GA and was founded in 1983. The company's focus is on developing innovative therapeutic options for gastrointestinal diseases and women's health. Sebela Pharmaceuticals® has a market-leading position in gastroenterology and is developing next-generation therapeutics with innovative features that help address the needs of women today. The CEO is Alan Cooke. | Health Technology |
